Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$26.00 Web:$23.40 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients) Ensuring an Infectious Disease Workforce: Education and Training Needs for the 21st Century - Workshop Summary Other Related Titles Monoclonal Antibody Production (1999) Institute for Laboratory Animal Research (ILAR) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 55   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix A Workshop on Methods of Producing Monoclonal Antibodies November 10, 1998 Agenda 9:00–9:30 Is the mouse ascites method painful?-Via Telephone Gebhart 9:30–3:00 Presentation by workshop participants: 9:30 - Mr. Tim DeSutter 9:45 - Dr. James Valdes 10:00 - Dr. John Reddington 10:15 - Break 10:30 - Dr. Simon Saxby 10:45 - Dr. Vahe Bedian 11:00 - Dr. Joseph Chandler 11:15 - Ms. Tracie Letterman 11:30 - Dr. Paul E. Thomas 11:45 - Questions and Answers 12:00 - Lunch for Committee and Workshop Participants 1:00 - Dr. Kathryn Stein 1:15 - Dr. Peter Maxim 1:30 - Dr. Dennis Dixon 1:45 - Dr. Arturo Casadevall 2:00 - Dr. John McArdle 2:15 - Dr. Louis Detolla 3:00 Adjourn Page 55 Front Matter (R1-R14) Executive Summary (1-4) Introduction (5-7) Generation of Hybridomas: Permanent Cell Lines Secreting Monoclonal Antibodies (8-11) In Vitro Production of Monoclonal Antibody (12-15) Scientific Needs for Mouse Ascites Production of mAb (16-21) Summary of Advantages and Disadvantages of In Vitro and In Vivo Methods (22-24) Large-Scale Production of Monoclonal Antibodies (25-32) Animal-Welfare Issues Related to the Ascites Method for Producing Monoclonal Antibodies (33-44) Conclusions and Recommendations (45-47) References (48-54) Appendix A: Workshop on Methods of Producing Monoclonal Antibodies (55-56) Appendix B: Biographical Sketches of Authoring Committee (57-60)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 55
Appendix A Workshop on Methods of Producing Monoclonal Antibodies November 10, 1998 Agenda 9:00–9:30 Is the mouse ascites method painful?-Via Telephone Gebhart 9:30–3:00 Presentation by workshop participants: 9:30 - Mr. Tim DeSutter 9:45 - Dr. James Valdes 10:00 - Dr. John Reddington 10:15 - Break 10:30 - Dr. Simon Saxby 10:45 - Dr. Vahe Bedian 11:00 - Dr. Joseph Chandler 11:15 - Ms. Tracie Letterman 11:30 - Dr. Paul E. Thomas 11:45 - Questions and Answers 12:00 - Lunch for Committee and Workshop Participants 1:00 - Dr. Kathryn Stein 1:15 - Dr. Peter Maxim 1:30 - Dr. Dennis Dixon 1:45 - Dr. Arturo Casadevall 2:00 - Dr. John McArdle 2:15 - Dr. Louis Detolla 3:00 Adjourn

OCR for page 56
Workshop Participants 1.   Dr.Vahe Bedian, Principal Research Investigator, Pfizer Central Research 2.   Dr. Arturo Casadevall, Department of Microbiology & Immunology, Albert Einstein College of Medicine 3.   Dr. Joseph Chandler, President, Maine Biotechnology Services, Inc. 4.   Mr. Tim DeSutter, Vice President, Integra Biosciences, Inc. 5.   Dr. Louis Detolla, Chairman, Comparative Medicine Program, University of Maryland 6.   Dr. Dennis Dixon, Chief, Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases, NIH/NIAID 7.   Ms. Tracie Letterman, Esquire, International Center for Technology Assessment 8.   Dr. Peter Maxim, FDA/CDRH 9.   Dr. John McArdle, Director, Alternatives Research and Development Foundation 10.   Dr. John Reddington, DiagXotics, Inc. 11.   Dr. Simon Saxby, Director, Contract Operations, Unisyn Technologies 12.   Dr. Kathryn Stein, Director, Division of Monoclonal Antibodies, FDA/CBER 13.   Dr. Paul E. Thomas, Professor, Department of Chemical Biology, Rutgers the State University 14.   Dr. James Valdes, Edgewood Research Development & Engineering Center

Representative terms from entire chapter:

kathryn stein